Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET

被引:0
|
作者
L. S. Freudenberg
G. Antoch
A. Frilling
W. Jentzen
S. J. Rosenbaum
H. Kühl
A. Bockisch
R. Görges
机构
[1] University of Duisburg/Essen,Department of Nuclear Medicine
[2] University of Duisburg/Essen,Department of Diagnostic and Interventional Radiology and Neuroradiology
[3] University of Duisburg/Essen,Department of General, Visceral and Transplantation Surgery
关键词
Thyroid cancer; PET; PET/CT; I; FDG; Thyroglobulin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:950 / 957
页数:7
相关论文
共 50 条
  • [1] Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography:: role of 124I-PET/CT and FDG-PET
    Freudenberg, L. S.
    Antoch, G.
    Frilling, A.
    Jentzen, W.
    Rosenbaum, S. J.
    Kuehl, H.
    Bockisch, A.
    Goerges, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 950 - 957
  • [2] Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
    Ina Binse
    Sandra Julia Rosenbaum-Krumme
    Andreas Bockisch
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1185 - 1186
  • [3] Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
    Vrachimis, A.
    Weckesser, M.
    Schaefers, M.
    Stegger, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) : 1183 - 1184
  • [4] Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
    A. Vrachimis
    M. Weckesser
    M. Schäfers
    L. Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1183 - 1184
  • [5] 124I-PET/CT in metastatic follicular thyroid carcinoma
    Freudenberg, LS
    Antoch, G
    Görges, R
    Knust, EJ
    Beyer, T
    Brandau, W
    Bockisch, A
    Debatin, JF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (08) : 1106 - 1106
  • [6] 124I-PET/CT in metastatic follicular thyroid carcinoma
    L. S. Freudenberg
    G. Antoch
    R. Görges
    E. J. Knust
    T. Beyer
    W. Brandau
    A. Bockisch
    J. F. Debatin
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 1106 - 1106
  • [7] The role of 124I-PET in diagnosis and treatment of thyroid carcinoma
    Lubberink, M.
    Fatah, S. Abdul
    Brans, B.
    Hoekstra, O. S.
    Teule, G. J. J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (01): : 30 - 36
  • [8] Intra-Individual Comparison of 124I-PET/CT and 124I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction
    Grafe, Hong
    Lindemann, Maike E.
    Weber, Manuel
    Kirchner, Julian
    Binse, Ina
    Umutlu, Lale
    Herrmann, Ken
    Quick, Harald H.
    CANCERS, 2022, 14 (13)
  • [9] FDG-PET in patients with thyroid carcinoma presenting with elevated thyroglobulin but negative iodine- and sestamibi-scans.
    Tatsch, K
    Weber, W
    Rossmuller, B
    Langhammer, HR
    Schwaiger, M
    Hahn, K
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 628 - 628
  • [10] Role of FDG-PET/CT in positive serum Thyroglobulin and negative radioiodine scan in differentiated thyroid carcinoma patients. A single center preliminary experience
    Munir, I.
    Nawaz, M. K.
    Farooqui, Z. S.
    Murtaza, A.
    Muzhair, S.
    Saadullah, M.
    Sajid, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S412 - S412